Koji Matsuo

14.6k total citations · 2 hit papers
517 papers, 7.8k citations indexed

About

Koji Matsuo is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Koji Matsuo has authored 517 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 284 papers in Obstetrics and Gynecology, 200 papers in Reproductive Medicine and 97 papers in Oncology. Recurrent topics in Koji Matsuo's work include Endometrial and Cervical Cancer Treatments (216 papers), Ovarian cancer diagnosis and treatment (163 papers) and Uterine Myomas and Treatments (81 papers). Koji Matsuo is often cited by papers focused on Endometrial and Cervical Cancer Treatments (216 papers), Ovarian cancer diagnosis and treatment (163 papers) and Uterine Myomas and Treatments (81 papers). Koji Matsuo collaborates with scholars based in United States, Japan and Germany. Koji Matsuo's co-authors include Lynda D. Roman, Hiroko Machida, Rachel S. Mandelbaum, Jason D. Wright, Anil K. Sood, Shinya Matsuzaki, Mikio Mikami, Maximilian Klar, Tadafumi Kato and Erin A. Blake and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Koji Matsuo

480 papers receiving 7.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States

2021 117 citations Shinya Matsuzaki, Rachel S. Mandelbaum et al. American Journal of Obstetrics and Gynecology profile →
National Estimates of Gender-Affirming Surgery in the US

2023 75 citations Jason D. Wright, Yukio Suzuki et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koji Matsuo United States	42	3.7k	2.7k	1.5k	1.4k	1.2k	517	7.8k
Clemens Tempfer Austria	52	1.9k 0.5×	2.6k 0.9×	1.9k 1.3×	1.1k 0.8×	2.1k 1.7×	374	9.2k
Jonathan L. Hecht United States	48	2.3k 0.6×	1.8k 0.6×	994 0.7×	1.1k 0.8×	808 0.7×	177	7.8k
Mark A. Morgan United States	45	2.2k 0.6×	1.8k 0.7×	1.4k 0.9×	654 0.5×	1.7k 1.4×	201	6.8k
Chiara Benedetto Italy	49	2.0k 0.5×	1.2k 0.4×	766 0.5×	895 0.6×	825 0.7×	405	9.2k
Sunghoon Kim South Korea	47	1.7k 0.5×	1.8k 0.6×	2.0k 1.4×	912 0.6×	2.5k 2.0×	405	9.0k
William P. Tew United States	44	990 0.3×	1.9k 0.7×	3.3k 2.2×	364 0.3×	1.5k 1.2×	217	9.3k
Masha Kocherginsky United States	43	1.3k 0.4×	457 0.2×	1.8k 1.2×	449 0.3×	903 0.7×	185	7.2k
Antti Kauppila Finland	46	1.8k 0.5×	2.6k 1.0×	713 0.5×	447 0.3×	583 0.5×	291	6.9k
Nobuyuki Amino Japan	53	820 0.2×	656 0.2×	766 0.5×	893 0.6×	1.3k 1.1×	363	11.6k
Charles H. Graham Canada	57	2.9k 0.8×	460 0.2×	2.0k 1.3×	511 0.4×	446 0.4×	175	10.7k

Countries citing papers authored by Koji Matsuo

Since Specialization

Citations

This map shows the geographic impact of Koji Matsuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Matsuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Matsuo more than expected).

Fields of papers citing papers by Koji Matsuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Matsuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Matsuo. The network helps show where Koji Matsuo may publish in the future.

Co-authorship network of co-authors of Koji Matsuo

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Matsuo. A scholar is included among the top collaborators of Koji Matsuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Matsuo. Koji Matsuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Jung‐Min, Austin Miller, Peter G. Rose, et al.. (2025). Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial. Clinical Cancer Research. 31(12). 2370–2378. 1 indexed citations

Matsuo, Koji, Kentaro Kamiya, Daichi Maeda, et al.. (2025). Fat Mass and Cause-Specific Death in Older Patients with Heart Failure. Canadian Journal of Cardiology. 1 indexed citations

Suzuki, Yukio, Ling Chen, Shayan Dioun, et al.. (2024). Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis. JNCI Journal of the National Cancer Institute. 116(5). 653–664. 2 indexed citations

Suzuki, Yukio, Jennifer S. Ferris, Ling Chen, et al.. (2024). Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 231(6). 599–610.e17. 9 indexed citations

Machida, Hiroko, Koji Matsuo, Takahiro Higashi, et al.. (2024). Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan. Journal of Gynecologic Oncology. 35(5). e61–e61.

Mandelbaum, Rachel S., Shinya Matsuzaki, Molly M. Quinn, et al.. (2023). The association between uterine adenomyosis and adverse obstetric outcomes: A propensity score‐matched analysis. Acta Obstetricia Et Gynecologica Scandinavica. 102(7). 833–842. 9 indexed citations

Mandelbaum, Rachel S., et al.. (2023). Assessment of abnormal placentation in pregnancies conceived with assisted reproductive technology. International Journal of Gynecology & Obstetrics. 163(2). 555–562. 4 indexed citations

Rau, Alesandra R., et al.. (2023). Unsuspected placenta accreta spectrum at vaginal delivery: Assessment of incidence, characteristics, and maternal morbidity. American Journal of Obstetrics and Gynecology. 228(1). S82–S83.

Matsuo, Koji, Shinya Matsuzaki, Alesandra R. Rau, et al.. (2023). Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas. JAMA Network Open. 6(6). e2318602–e2318602. 12 indexed citations

10.

Nishio, Shin, Koji Matsuo, Shinya Matsuzaki, et al.. (2021). Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva: A Japanese Gynecologic Oncology Group study. European Journal of Surgical Oncology. 47(12). 3188–3193. 1 indexed citations

11.

Matsuzaki, Shinya, Shinya Matsuzaki, Satoshi Serada, et al.. (2021). CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer. Cancer Science. 112(9). 3655–3668. 13 indexed citations

12.

Guo, Xiaoyue, Heather Miller, Koji Matsuo, Lynda D. Roman, & Bodour Salhia. (2021). Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature. Cancers. 13(4). 838–838. 15 indexed citations

13.

Silva, Diane M. Da, Danielle Enserro, Jyoti Mayadev, et al.. (2020). Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929). Clinical Cancer Research. 26(21). 5621–5630. 54 indexed citations

14.

Matsuo, Koji, Hiroko Machida, Shinya Matsuzaki, et al.. (2020). Evolving population-based statistics for rare epithelial ovarian cancers. Gynecologic Oncology. 157(1). 3–11. 17 indexed citations

15.

Matsuo, Koji, Akira Yabuno, Marianne S. Hom, et al.. (2018). Significance of abnormal peritoneal cytology on survival of women with stage I–II endometrioid endometrial cancer. Gynecologic Oncology. 149(2). 301–309. 38 indexed citations

16.

Roh, Ju‐Won, Jie Huang, Wei Hu, et al.. (2014). Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer. Clinical Cancer Research. 20(10). 2740–2750. 15 indexed citations

17.

Matsuo, Koji, Todd Sheridan, Kiyoshi Yoshino, et al.. (2012). Significance of lymphovascular space invasion in epithelial ovarian cancer. Cancer Medicine. 1(2). 156–164. 36 indexed citations

18.

Matsuo, Koji, Edward H. Ahn, Annie A. Yessaian, et al.. (2012). Significance of Perioperative Infection in Survival of Patients With Ovarian Cancer. International Journal of Gynecological Cancer. 22(2). 245–253. 35 indexed citations

19.

Merritt, William M., Alpa M. Nick, Amy R. Carroll, et al.. (2010). Bridging the Gap between Cytotoxic and Biologic Therapy with Metronomic Topotecan and Pazopanib in Ovarian Cancer. Molecular Cancer Therapeutics. 9(4). 985–995. 47 indexed citations

20.

Morioka, Seiji, et al.. (2006). A Food-Borne Norovirus Outbreak at a Primary School in Wakayama Prefecture. Japanese Journal of Infectious Diseases. 59(3). 205–207. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact